Zhejiang Jingxin Pharmaceutical Co Ltd (002020) — Free Cash Flow Generation Index
Zhejiang Jingxin Pharmaceutical Co Ltd (002020) has a Free Cash Flow Generation Index of 0.84x as of September 2025. Free cash flow of CN¥192.09 Million represents 1% of operating cash flow (CN¥227.64 Million). Read how much debt does Zhejiang Jingxin Pharmaceutical Co Ltd carry for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Zhejiang Jingxin Pharmaceutical Co Ltd Free Cash Flow Generation Index (2002–2025)
Historical FCF Generation Index trend for Zhejiang Jingxin Pharmaceutical Co Ltd across 22 annual periods. Explore 002020 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Zhejiang Jingxin Pharmaceutical Co Ltd (2002–2025)
Year-by-year Free Cash Flow Generation Index for Zhejiang Jingxin Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Zhejiang Jingxin Pharmaceutical Co Ltd (002020) total market value.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.74x | CN¥578.50 Million | CN¥781.35 Million | CN¥202.85 Million | ▲ +13.1% |
| 2024 | 0.65x | CN¥475.52 Million | CN¥726.16 Million | CN¥250.65 Million | ▲ +97.6% |
| 2023 | 0.33x | CN¥273.32 Million | CN¥824.69 Million | CN¥519.51 Million | ▼ -16.6% |
| 2022 | 0.40x | CN¥340.20 Million | CN¥855.78 Million | CN¥515.57 Million | ▲ +468.2% |
| 2021 | -0.11x | CN¥-39.41 Million | CN¥365.02 Million | CN¥404.43 Million | ▼ -130.9% |
| 2020 | 0.35x | CN¥179.21 Million | CN¥513.21 Million | CN¥334.00 Million | ▼ -5.6% |
| 2019 | 0.37x | CN¥197.97 Million | CN¥535.30 Million | CN¥337.33 Million | ▼ -31.2% |
| 2018 | 0.54x | CN¥281.21 Million | CN¥523.40 Million | CN¥242.19 Million | ▼ -24.2% |
| 2017 | 0.71x | CN¥272.82 Million | CN¥385.01 Million | CN¥112.19 Million | ▲ +13.7% |
| 2016 | 0.62x | CN¥157.43 Million | CN¥252.69 Million | CN¥95.26 Million | ▲ +196.7% |
| 2015 | 0.21x | CN¥30.39 Million | CN¥144.69 Million | CN¥114.31 Million | ▼ -61.8% |
| 2014 | 0.55x | CN¥115.74 Million | CN¥210.49 Million | CN¥94.75 Million | ▲ +2117.5% |
| 2013 | 0.02x | CN¥2.75 Million | CN¥111.03 Million | CN¥108.28 Million | ▲ +106.4% |
| 2012 | -0.39x | CN¥-23.23 Million | CN¥60.28 Million | CN¥83.51 Million | ▼ -993.9% |
| 2011 | -0.04x | CN¥-2.45 Million | CN¥69.41 Million | CN¥71.86 Million | ▲ +97.8% |
| 2010 | -1.62x | CN¥-96.32 Million | CN¥59.55 Million | CN¥155.87 Million | ▼ -290.1% |
| 2009 | 0.85x | CN¥115.20 Million | CN¥135.38 Million | CN¥20.18 Million | ▲ +284.5% |
| 2008 | -0.46x | CN¥-13.83 Million | CN¥29.98 Million | CN¥43.81 Million | ▲ +60.9% |
| 2005 | -1.18x | CN¥-72.85 Million | CN¥61.82 Million | CN¥134.67 Million | ▲ +91.7% |
| 2004 | -14.26x | CN¥-91.68 Million | CN¥6.43 Million | CN¥98.11 Million | ▼ -2531.7% |
| 2003 | -0.54x | CN¥-25.01 Million | CN¥46.18 Million | CN¥71.19 Million | ▼ -973.6% |
| 2002 | -0.05x | CN¥-2.30 Million | CN¥45.50 Million | CN¥47.79 Million | — |